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HIV-associated disruption of lung
cytokine networks is incompletely
restored in asymptomatic HIV-infected
Malawian adults on antiretroviral therapy
To the Editor:
The lung is the site most commonly affected by infectious and non-infectious complications of HIV
infection [1], even in individuals on effective antiretroviral therapy (ART). HIV infection is associated with
lymphocytic alveolitis [2], a condition characterised by the influx of CD8+ T-cells into the alveolar space.
This is thought to occur in response to HIV antigens and forms part of the host response to the presence
of HIV in the lung [2, 3]. Excessive influx of inflammatory cells in the lung probably leads to tissue
damage, disruption of immune cell homeostasis, impaired gas exchange [4] and predisposition to
HIV-associated lung complications.
The cytokine microenvironment in the lung plays a crucial role in shaping the cellular composition and
immune response in this compartment [5]. We have previously shown that antigen-specific CD4+ T-cell
responses to respiratory pathogens differ both in quality and magnitude between alveolar and peripheral
blood CD4+ T-cells [6]. Furthermore, impairment of CD4+ T-cell responses to Mycobacterium tuberculosis
and influenza virus in HIV-infected adults was more pronounced in alveolar than peripheral blood cells [6],
indicating that immune responses are compartmentalised and are impacted differentially by HIV infection.
Cytokines function in clusters of organised integrated networks that maintain homeostasis and immune
surveillance in the systemic and tissue compartments. While the integrity of cytokine networks in plasma
was shown to impact HIV disease progression during acute HIV infection, with rapid disease progressors
having more dysregulated cytokine networks than slow progressors [7], the impact of chronic HIV
infection or ART on the cytokine microenvironment and immune cell homeostasis in the lung is
incompletely understood.
We hypothesised that chronic HIV infection alters the lung cytokine microenvironment in a manner that
promotes accumulation of lymphocytes in the alveolar space. We explored this hypothesis in a prospective
cross-sectional study that recruited healthy HIV-1-uninfected and asymptomatic HIV-1-infected
ART-naïve and ART-treated adults (aged ⩾18 years) for assessment of lung immunity. Clients attending
the HIV voluntary counselling and testing (VCT) and ART clinics at Queen Elizabeth Central Hospital in
Blantyre, Malawi, were invited to join the study. Exclusion criteria were current or previous history of
smoking, use of immunosuppressive drugs, severe anaemia (Hb <8 g·dL−1) and known or suspected
pregnancy. The research ethics committee of the Malawi College of Medicine approved the study and all
participants provided written informed consent.
Participants underwent bronchoscopy for bronchoalveolar lavage (BAL) fluid sampling [3]. The levels of
34 cytokines (interleukin (IL)-12, IL-23, IL-27, monocyte chemoattractant protein (MCP)-1 (CCL2),
RANTES (CCL5), GRO-α (CXCL1), stromal cell-derived factor (SDF)-1α (CXCL12),
interferon-γ-inducible protein (IP)-10 (CXCL10), Eotaxin, granulocyte–macrophage colony-stimulating
factor (GM-CSF), interferon (IFN)-α, IFN-γ, IL-1α, IL-1β, IL-1RA, IL-10, IL-13, IL-15, IL-17A, IL-18,
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IL-2, IL-21, IL-22, IL-31, IL-4, IL-5, IL-6, IL-7, IL-8 (CXCL8), IL-9, macrophage inflammatory protein
(MIP)-1α, MIP-1β, tumour necrosis factor (TNF)-α and TNF-β) were measured in concentrated cell-free
BAL fluid using a ProcartaPlex 34-plex Human Cytokine and Chemokine Panel 1A (Affymetrix
eBioscience, USA) and reported as the cytokine concentration per mL of epithelial lining fluid following
standardisation using the urea dilution method [8]. Statistical analysis and graphical presentation were
performed using GraphPad Prism 5 (GraphPad Software, USA) or R statistical software version 3.2.4
(www.r-project.org). We performed intergroup comparisons using the Kruskal–Wallis test with Dunn’s
multiple comparisons test or with the Mann–Whitney U-test. Associations were analysed using
Spearman’s test. Differences were considered statistically significant when p<0.05.
We recruited 21 HIV-uninfected (median age (range) 25 (18–40) years), 33 ART-naïve HIV-infected (35
(20–52) years) and 20 ART-treated HIV-infected (36 (20–52) years) adults. The male:female ratio was 3:1
in HIV-uninfected, 2:3 in ART-naïve and 1:1 in ART-treated HIV-infected participants. Median
(interquartile range, IQR) CD4+ T-cell counts were 647 (536–757) cells/µL in HIV-uninfected, 331
(256–428) cells·L−1 in ART-naïve and 383 (194–627) cells·L−1 in ART-treated HIV-infected participants.
The median (IQR) plasma HIV viral load was 25638 (11140–251011) copies·mL−1 in ART-naive and
2304 (295–87436) copies·mL−1 in 4 ART-treated HIV-infected individuals (the remaining 16 had HIV
viral loads of <150 copies·mL−1, the lower limit of detection of the assay). ART consisted of tenofovir,
lamivudine and efavirenz, with a median duration of treatment of 5.5 years (range 0.1–10 years).
Analysis of BAL fluid cytokine levels showed significantly higher concentrations of RANTES and TNF-β in
ART-naïve HIV-infected than in HIV-uninfected participants (all p<0.05; figure 1a and b). Cytokine levels
were not significantly different between HIV-uninfected and ART-treated HIV-infected participants (figure
1a and b). We next assessed the inter-cytokine relationships to identify the key cytokine networks disrupted
during chronic HIV infection. We constructed cytokine networks by pooling data from only those
associations that showed strong correlations (r⩾0.80, p<0.05) and found that fewer cytokines strongly
correlated with each other in ART-naïve HIV-infected than in HIV-uninfected individuals (figure 1c–e). We
then grouped the cytokines based on their functional profiles into inflammatory, anti-inflammatory,
adaptive, haematopoietic and chemokines (figure 1c–e). Compared with HIV-uninfected individuals,
ART-naïve HIV-infected participants had disrupted cytokine networks, with predominance of
chemokine-driven networks (comprising SDF-1α, MIP-1α, MIP-1β, MCP-1, IP-10, GRO-α, Eotaxin and
IL-8) and a marked reduction in the other cytokine networks (figure 1f–h). Furthermore, the
RANTES-driven network was severely depleted in ART-naïve HIV-infected adults but remained strongly
correlated with SDF-1α (figure 1c–h). Interestingly, the SDF-1α-driven network was the most dominant in
ART-naïve HIV-infected individuals and showed strong associations with MIP-1α, MIP-1β, MCP-1, IP-10,
GRO-α, Eotaxin and IL-8 (figure 1c–h). ART-treated HIV-infected individuals had re-emergence of cytokine
networks that partially resembled those observed in HIV-uninfected individuals (figure 1c–h).
Dysregulated BAL fluid cytokine profiles have been reported in respiratory conditions such as asthma [9] and
IgG4-related respiratory disease [10]. Here, we show that chronic HIV infection was associated with
disruption of key cytokine networks involved in immune defence and maintenance of immune cell
homeostasis in the lung. RANTES and SDF-1α are major lymphocyte chemoattractants that have been shown
to play a crucial role in recruitment of CD8+ T-cells to the lung in murine models of respiratory syncytial
virus (RSV) infection [11] and obliterative bronchiolitis [12]. CD8+ T-cells and alveolar epithelial cells (AECs)
are among the main producers of RANTES in the lung, while SDF-1α, a potent inducer of HIV-specific
CD8+ T-cell chemotaxis, is produced mainly by AECs and fibroblasts [13]. HIV-specific CD8+ T-cells are
known producers of TNF-β upon stimulation with HIV antigens [14]. The influx of HIV-specific CD8+
T-cells into the alveolar space may explain the increase in TNF-β levels in BAL fluid of ART-naïve
HIV-infected individuals. RANTES and SDF-1α are ligands for the CCR5 and CXCR4 receptors, respectively.
Both chemokines have antiviral properties against HIV by blocking attachment and entry of HIV into cells
through the CCR5 and CXCR4 HIV co-receptors [15]. The strong positive association between RANTES,
SDF-1α and other known cell chemoattractants (IL-8, MIP-1α, MIP-1β, MCP-1, IP-10 and Eotaxin) is
evidence of the tightly integrated networks in which these chemokines function. The predominance of the
chemokine-driven networks in the alveolar space during chronic HIV infection is probably a double-edged
sword; on the one hand it is a beneficial antiviral response against HIV infection, but on the other it disrupts
immune cell homeostasis by promoting excessive recruitment of CD8+ T-cells to the lung.
In conclusion, the lung cytokine microenvironment was profoundly perturbed in individuals with
untreated chronic HIV-1 infection and was incompletely restored by long-term ART. This contributes to
the high risk of HIV-associated lung complications such as tuberculosis and pneumococcal pneumonia.
RANTES, SDF-1α and associated chemokines are the likely key drivers of lymphocyte accumulation in the
alveolar space during chronic HIV infection.
https://doi.org/10.1183/23120541.00097-2017 2
ORIGINAL RESEARCH LETTER | K.C. JAMBO ET AL.
R
AN
TE
S 
co
nc
en
tr
at
io
n
pg
·m
L–
1 
5
p=0.024
4
3
2
1.5
1.0
0.5
0.0
HIV- HIV+ART- HIV+ART+
p=0.352a)
TN
F-
β c
on
ce
nt
ra
tio
n 
pg
·m
L–
1 
5
p=0.011
4
3
2
1
1.0
0.5
0.0
HIV- HIV+ART- HIV+ART+
p>0.999b)
c) d)
e)
IL-8
TNF-α
IL-18
IFN-γ
IL-13
IL-22
GM-CSF
IL-27
IL-15
IL-12p
IL-31
IL-2
IL-23
IL-9
IL-10
TNF-β
IL-21
IFN-α
MIP-1α
IL-1α
RANTES
MIP-1β
IL-7
MCP-1
Eotaxin
GRO-α
IL-10
IL-18
IL-7
IP-10
IL-15
TNF-α
IL-22
IL-31
IL-2
IL-4
MIP-1α
SDF-1α
IL-12p70
IL-27
IL-21
MIP-1β
RANTES
IFN-1α IL-1α
IL-13 Eotaxin
GM-CSF
IL-6
IL-8 GRO-α
IL-1β
MCP-1
IL-23
IFN-γ
IL-17A
IL-9
IL-1RA
TNF-β
SDF-1α
IL-4
IL-17A
IL-1β
IL-6
IP-10
IL-1β
IL-1RA
IP-10
IL-7
MIP-1βIL-1α
Eotaxin
GRO-α
SDF-1α
IL-8
MIP-1α
MCP-1
RANTES
IL-6 IL-13
GM-CSF
IL-9
IL-23
IL-4
TNF-β
IL-31
IL-1RA
IL-18
IFN-γ TNF-α
IL-12p70
IL-21
IL-22
IL-10
IL-15
IL-27
IL-17A
IL-2
IFN-α
FIGURE 1 Scatter plots showing the concentration of a) RANTES (CCL5) and b) tumour necrosis factor (TNF)-β
in bronchoalveolar lavage (BAL) fluid from HIV-uninfected adults compared to untreated and treated
HIV-infected individuals. Bars represent the median and error bars are 95% confidence intervals. Data were
analysed using the Kruskal–Wallis test with Dunn’s multiple comparisons test. Network graphs of the
cytokine associations among 33 BAL fluid cytokines for c) HIV-uninfected individuals, d) antiretroviral therapy
(ART)-naïve HIV-infected individuals and e) HIV-infected individuals on long-term ART. The shorter the
connecting line between the circles, the greater the magnitude of the correlation. Bar graphs showing the
number of associations per cytokine in BAL fluid for f) HIV-uninfected individuals, g) ART-naïve HIV-infected
individuals and h) HIV-infected individuals on ART. Only correlations >0.80 with p<0.05 were considered in this
analysis (HIV−, n=21; HIV+ ART−, n=33; HIV+ ART+, n=20). SDF: stromal cell-derived factor; MIP: macrophage
inflammatory protein; MCP: monocyte chemoattractant protein; IP: interferon-γ-inducible protein; IL; interleukin;
GM-CSF: granulocyte–macrophage colony-stimulating factor; IFN: interferon; IL1RA: IL-1 receptor antagonist.
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